Efficacy and safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) patients : A randomized, double-blind, active-controlled, multicenter phase 3 clinical trial

Trial Profile

Efficacy and safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) patients : A randomized, double-blind, active-controlled, multicenter phase 3 clinical trial

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2013

At a glance

  • Drugs Levocetirizine/montelukast (Primary) ; Levocetirizine; Montelukast
  • Indications Perennial allergic rhinitis
  • Focus Therapeutic Use
  • Acronyms MOLZ
  • Most Recent Events

    • 05 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Feb 2013 Planned End Date changed from 1 Mar 2013 to 31 Mar 2013 as reported by Korean Clinical Trials Register.
    • 01 Aug 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000484).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top